These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 11350463

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].
    Danner K, Becker HG, Best B, Madler C.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):425-30. PubMed ID: 11496617
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dolasetron, but not metoclopramide prevents nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
    Piper SN, Suttner SW, Röhm KD, Maleck WH, Larbig E, Boldt J.
    Can J Anaesth; 2002 Dec; 49(10):1021-8. PubMed ID: 12477671
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery.
    Frighetto L, Loewen PS, Dolman J, Marra CA.
    Can J Anaesth; 1999 Jun; 46(6):536-43. PubMed ID: 10391600
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prophylaxis of nausea and vomiting after pelviscopy. Dolasetron or MCP in comparison with placebo].
    Rüsch D, Bernhardt J, Wulf H.
    Anaesthesist; 1999 Oct; 48(10):705-12. PubMed ID: 10551919
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized, double-blind trial of dolasetron versus droperidol for prophylaxis of postoperative nausea and vomiting in patients undergoing TRAM flap breast reconstruction surgery.
    Loewen P, Lamb S, Clugston P.
    Ann Plast Surg; 2003 Nov; 51(5):472-7. PubMed ID: 14595183
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
    Chevallier B, Cappelaere P, Splinter T, Fabbro M, Wendling JL, Cals L, Catimel G, Giovannini M, Khayat D, Bastit P, Claverie N.
    Support Care Cancer; 1997 Jan; 5(1):22-30. PubMed ID: 9010986
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prophylactic oral dolasetron mesylate reduces nausea and vomiting after abdominal hysterectomy. The Canadian Dolasetron Study Group.
    Warriner CB, Knox D, Belo S, Cole C, Finegan BA, Perreault L.
    Can J Anaesth; 1997 Nov; 44(11):1167-73. PubMed ID: 9398956
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
    Sukhani R, Pappas AL, Lurie J, Hotaling AJ, Park A, Fluder E.
    Anesth Analg; 2002 Nov; 95(5):1230-5, table of contents. PubMed ID: 12401599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.